IL4R and neoplasm: In the tumor microenvironment (TME), IL‐4 elicits an increased Th2 response and activates myeloid‐derived suppressor cells (MDSCs) and tumor‐associated macrophages (TAMs), both of which express the IL‐4R, to promote immunosuppression and angiogenesis [2].